 | • レポートコード：C-MOR-100206 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、牛健康の世界市場について調査・分析し、牛健康の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
The market for cattle health is being driven by factors such as increasing R&D expenditure in the cattle health sector, rising government initiatives, and insurance policies across various countries, and advanced technology leading to innovations in the cattle health sector.
European countries along with the countries in the Asia Pacific are focusing more on the cattle health and implementing several initiatives for the same. For instance, in the United Kingdom, the Cattle Health and Welfare Group (CHAWG) has a crucial role in addressing relevant cattle health and welfare issues. CHAWG is responsible for planning and coordinating a program of economically-focused improvements for cattle health and welfare. CHAWG acts as the first point of call for all cattle health and welfare research, and new disease challenges. Also, countries such as the Netherlands and Germany are having private and public-private partnership insurance schemes are available for cattle, which compensate for consequential losses. In Italy, private insurance schemes are exclusively for dairy production and sheep, but participation is very limited.
Considering the Asia Pacific region, in Australia, the Animal Welfare Task Group developed animal welfare standards and guidelines for cattle and sheep. In addition, an electronic identification system has been developed for the livestock, named national livestock identification system (NLIS), in which, an animal is tagged with a radiofrequency identification device.
Owing to the rising focus on cattle health and involvement of the government, it is expected that the market for cattle health will grow in the coming future.
Scope of the Report
Cattle healthcare includes the treatment and diagnosis of cattle. Cattle healthcare is being fueled by the increasing beef consumption and rising demand for animal protein in the market.
Key Market Trends
Vaccines are Expected to Dominate the Product Segment Over the Forecast Period.
Vaccination of the beef cattle herds is designed to protect the cattle from different kinds of microorganisms, such as viruses, bacteria, and protozoans. Most of the vaccines used for cattle are injectables. However, some of the vaccines are given by intranasal or oral route.
The vaccines used for cattle health include modified live organisms, killed or chemically altered organisms. With the right use of the vaccine, cattle’s resistance toward the disease may be increased, irrespective of the type of vaccine used. The modified live vaccines contain little amount of viruses or bacteria, which are used for the single-dose purpose and may not develop allergic reactions in the cattle.
The killed vaccines or toxoids are available for various types of disease and are likely to cause allergic reactions. The chemically altered vaccines show similar results like the modified live vaccines. The increasing R&D expenditure and latest technologies are helping the vaccine segment to expand its reach to a broad spectrum of diseases. The market is inclusive of different kind of vaccines, such as vaccination for respiratory diseases, clostridial vaccines, botulism vaccine, and vaccination for diseases that cause infertility or abortion in the cattle. In addition to the above-mentioned list, vaccines are also available for some of the specific diseases, such as bovine ephemeral fever, anthrax, tick fever, etc.
The availability of such vaccines is the result of R&D efforts taken by the companies and the increasing awareness among people about cattle health.
North America Dominates the Market
North America is believed to dominate the market due to increasing R&D expenditure in cattle health and advanced technology leading to innovations in the cattle health sector in this country, which, in turn, helps in the growth of this market.
Due to the huge demand for dairy products in the United States, there is a huge requirement of cattle population. Cattle health products are very important for maintaining cattle health and to increase the cattle population. However, the registration of new cattle health products or import of the same requires to go through various tests and certifications, before being allowed to enter the market.
Competitive Landscape
The cattle health market includes the major players such as Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc, Elanco, IDVet, Merck, Virbac, and Zoetis Animal Healthcare, amongst others. Few of the companies such as Elanco, Ceva, Zoetis Animal Health, etc. are dominating the market and there are some local players which are holding a substantial share.
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Expenditure in the Cattle Health Sector
4.2.2 Increasing Initiatives by Governments and Insurance Policy in Different Countries
4.2.3 Advanced Technology Leading to Innovations in the Cattle Health Sector
4.3 Market Restraints
4.3.1 Regulatory Challenges and Incompatible Cattle Health
4.3.2 Lack of Infrastructure and Funding
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Vaccine
5.1.2 Parasiticide
5.1.3 Anti-infective
5.1.4 Medical Feed Additive
5.1.5 Other Product Types
5.2 By Type of Diagnostics
5.2.1 Immunodiagnostic Test
5.2.2 Molecular Diagnostics
5.2.3 Diagnostic Imaging
5.2.4 Clinical Chemistry
5.2.5 Other Types of Diagnostics
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Zoetis Animal Healthcare
6.1.2 Merck
6.1.3 IDVet
6.1.4 Elanco
6.1.5 Bayer Healthcare
6.1.6 Ceva Animal Health Inc.
6.1.7 Virbac
6.1.8 Boehringer Ingelheim
6.1.9 Idexx Laboratories
7 MARKET OPPORTUNITIES AND FUTURE TRENDS